Targeting frailty in pre-lung transplant patients might improve survival rates, patient outcomes

December 17, 2015

ROCHESTER, Minn. -- Frailty can affect people of all ages and demographics. Defined simply as "an increased vulnerability to adverse health outcomes," frailty can affect a patient's chances of surviving a surgical procedure or needing a nursing home. A new study from physicians at Mayo Clinic in Rochester, Minn., published recently in the Journal of Heart and Lung Transplantation, is among the first to show a definitive connection between frailty and survival after a lung transplant procedure.

Mayo Clinic researchers studied 102 individuals who received lung transplants at Mayo Clinic between Jan. 1, 2002, and Dec. 31, 2013, and found that patients who were frail had a decreased survival rate compared to patients who were not frail.

According to the report, 46 percent of the patients studied were considered to be frail based on an assessment of 14 activities of daily living, such as difficulty climbing stairs, dependency on oxygen or noninvasive ventilation for normal breathing and difficulty with housekeeping chores. Of those considered to be frail, 63 percent were female with an average age of 57. Within this study population, there were 32 deaths within the first three years post-transplant.

"Based on this population, we saw a definitive association between pre-transplant frailty and decreased survival after transplantation," says Cassie Kennedy, M.D., Pulmonology and Critical Care Medicine, Mayo Clinic. "This suggests that we may be able to help patients live longer with fewer complications after a transplant by intervening early to prevent or lessen the severity of frailty."

According to Dr. Kennedy, Mayo Clinic researchers found that the one-year survival rate for frail patients was 71.7 percent, compared to 92.9 percent for patients who were not frail. At three years, the survival rate for frail patients was 41.3 percent, compared to 66.1 percent for patients who were not frail.

"Understanding the connection between frailty and lung transplant survival and outcomes can help physicians deliver a more accurate prognosis for transplant patients and, ultimately, get patients and their families engaged in taking steps to improve long-term outcomes and survival," says Dr. Kennedy.

Kennedy adds that future studies in this area will more clearly define the role that frailty plays in identifying candidates for lung transplantation, with the potential to influence selection guidelines and transplant center policies.
-end-


Mayo Clinic

Related Transplantation Articles from Brightsurf:

A revolutionary new treatment alternative to corneal transplantation
A new approach in ophthalmology that offers a revolutionary alternative to corneal transplantation has just been developed by researchers and clinicians in North America, Europe, and Oceania.

Fewer complications after organ transplantation
A large international study coordinated by University Hospital Regensburg and Charité - Universitätsmedizin Berlin has demonstrated the safety of new cell therapy approaches for use in kidney transplant recipients.

Elderly patients also benefit from kidney transplantation
So far, kidney transplantation has generally not been offered to elderly patients (>75 years) because of the perioperative risks.

New material will allow abandoning bone marrow transplantation
Scientists from the National University of Science and Technology 'MISIS' developed nanomaterial, which will be able to restore the internal structure of bones damaged due to osteoporosis and osteomyelitis.

Fewer medical tests -- timely listing for transplantation
Younger patients would benefit greatly from kidney transplantation. Their expected remaining lifetime may even be doubled by having a transplant.

Uterus transplantation -- ethically just as problematic as altruistic surrogacy
In 2014, the first child to have been gestated in a donated uterus was born.

Advancing transplantation: Hepatitis C-infected organs safe for transplantation when followed by antiviral treatment
Twenty patients at Penn Medicine have been cured of the hepatitis C virus (HCV) following lifesaving kidney transplants from deceased donors who were infected with the disease, according to a study published today in Annals of Internal Medicine.

Transplantation followed by antiviral therapy cured hepatitis C
Twenty patients who received kidneys transplanted from hepatitis C virus (HCV)-infected donors experienced HCV cure, good quality of life, and excellent renal function at one year.

The Journal of Heart and Lung Transplantation: 50 years of heart transplantation progress
This month marks the 50th anniversary of the world's first human heart transplant performed at Groote Schuur Hospital in Cape Town by South African surgeon, Christiaan Barnard.

Older donor lungs should be considered for transplantation
With a scarcity of lungs available for transplantation, the use of lungs from donors older than age 60 has been shown to achieve reasonable outcomes and should be considered as a viable option, according to research published online today in The Annals of Thoracic Surgery.

Read More: Transplantation News and Transplantation Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.